MDRX.OTC.PinkVeradigm INC

Form 4: Veradigm Director Receives Stock Units

Sentiment:

Insider Transaction


Veradigm Inc. director David B. Stevens was granted 42,507 Restricted Stock Units on June 1, 2026, as part of the company's 2024 Stock Incentive Plan.

Summary

  • David B. Stevens, a Director at Veradigm Inc., was granted 42,507 Restricted Stock Units (RSUs) on June 1, 2026.
  • These RSUs were awarded under the Veradigm Inc. Amended and Restated 2024 Stock Incentive Plan.
  • The RSUs will automatically convert into Deferred Stock Units (DSUs) on the first anniversary of the grant date.
  • This conversion is based on an election made by Mr. Stevens under the Veradigm Inc. Director Deferred Compensation Plan.
  • The DSUs will be settled in shares of common stock on the tenth business day of January following the year Mr. Stevens ceases to be a director.
  • Following this transaction, Mr. Stevens beneficially owns 163,509 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard equity award to a director and does not contain new financial performance data or strategic shifts.

Positives

  • Director compensation through equity awards, indicating alignment with shareholder interests.
  • Grant of 42,507 Restricted Stock Units to a director.
  • Potential for future share ownership through the conversion to Deferred Stock Units.

Risks

  • The value of the awarded stock units is subject to market fluctuations and the future performance of Veradigm Inc.
  • The settlement of Deferred Stock Units is contingent upon the director's continued service and eventual departure from the board.

Future Outlook

The future outlook for the awarded equity is tied to the company's stock performance and the director's continued service. The settlement of Deferred Stock Units is scheduled for January of the calendar year following the calendar year in which the recipient ceases to be a director.

Industry Context

StockSavvy.ai notes that the issuance of Restricted Stock Units to directors is a common practice in the healthcare technology sector to incentivize long-term commitment and align executive interests with those of shareholders. This aligns with industry trends of performance-based compensation.

Related Party Transactions

  • Grant of 42,507 Restricted Stock Units to Director David B. Stevens under the company's stock incentive plan.

Stakeholder Impact

  • Shareholders: The issuance of RSUs represents a form of compensation that dilutes existing ownership slightly, but also aims to align director incentives with long-term shareholder value.
  • Employees: The stock incentive plan may set a precedent for employee compensation structures.
  • Management: The award reinforces the company's compensation strategy for its board members.

Next Steps

  • Conversion of Restricted Stock Units to Deferred Stock Units on June 1, 2027.
  • Settlement of Deferred Stock Units in shares of common stock on the tenth business day of January following the calendar year in which Mr. Stevens ceases to be a director.

Key Dates

DateDescription
06/01/2026Grant Date of Restricted Stock Units.
06/03/2026Date of filing for the Statement of Changes in Beneficial Ownership.
06/01/2027First anniversary of the Grant Date, on which RSUs will convert to DSUs.
January following cessation of directorshipSettlement date for Deferred Stock Units.

Keywords

Veradigm Inc., MDRX, Form 4, Restricted Stock Units, Deferred Stock Units, Director Compensation, Stock Incentive Plan, Beneficial Ownership, Insider Trading

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.